Loading clinical trials...
Loading clinical trials...
A Randomized Double Blinded Placebo Controlled Oral Selenium Therapy for the Prevention of Mucositis in Patients Undergoing High Dose Chemotherapy With Hematopoietic Stem Cell Transplantation
Conditions
Interventions
Oral selenium
Oral placebo
Locations
1
Iran
Hematology-Oncology & SCT Research Center
Tehran, Iran
Start Date
June 1, 2011
Primary Completion Date
October 1, 2012
Completion Date
December 1, 2012
Last Updated
June 4, 2012
NCT07101588
NCT05436418
NCT06093867
NCT04146870
NCT05853692
NCT06305000
Lead Sponsor
Tehran University of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions